Acquired skeletal muscle metabolic myopathy in atherosclerotic peripheral arterial disease.
about
Mitochondrial Regulation of the Muscle Microenvironment in Critical Limb IschemiaExercise rehabilitation in peripheral artery disease: functional impact and mechanisms of benefitsEvaluation of trans sodium crocetinate on safety and exercise performance in patients with peripheral artery disease and intermittent claudicationSkeletal muscle-specific genetic determinants contribute to the differential strain-dependent effects of hindlimb ischemia in mice.Angiogenesis in skeletal muscle precede improvements in peak oxygen uptake in peripheral artery disease patientsRelationship between leg muscle capillary density and peak hyperemic blood flow with endurance capacity in peripheral artery disease.Multifactorial determinants of functional capacity in peripheral arterial disease: uncoupling of calf muscle perfusion and metabolism.A functional murine model of hindlimb demand ischemia.Exercise in claudicants increase or decrease walking ability and the response relates to mitochondrial function.Haemodynamic limitations and exercise performance in peripheral arterial disease.Surface-enhanced Raman spectral biomarkers correlate with Ankle Brachial Index and characterize leg muscle biochemical composition of patients with peripheral arterial disease.Abnormal accumulation of desmin in gastrocnemius myofibers of patients with peripheral artery disease: associations with altered myofiber morphology and density, mitochondrial dysfunction and impaired limb function.Muscle cell derived angiopoietin-1 contributes to both myogenesis and angiogenesis in the ischemic environment.High-molecular-weight and total adiponectin levels and incident symptomatic peripheral artery disease in women: a prospective investigation.Abnormal myofiber morphology and limb dysfunction in claudication.The ankle-brachial index is associated with the magnitude of impaired walking endurance among men and women with peripheral arterial disease.Transforming growth factor-beta 1 produced by vascular smooth muscle cells predicts fibrosis in the gastrocnemius of patients with peripheral artery disease.Vascular occlusion affects gait variability patterns of healthy younger and older individuals.Chronically ischemic mouse skeletal muscle exhibits myopathy in association with mitochondrial dysfunction and oxidative damage.Gait kinematics and kinetics are affected more by peripheral arterial disease than by ageDivergent systemic and local inflammatory response to hind limb demand ischemia in wild-type and ApoE-/- miceMorphometric analysis of gastrocnemius muscle biopsies from patients with peripheral arterial disease: objective grading of muscle degeneration.Human enterovirus in the gastrocnemius of patients with peripheral arterial disease.Physiology in medicine: peripheral arterial diseaseOxidative damage and myofiber degeneration in the gastrocnemius of patients with peripheral arterial disease.Walking disability in patients with peripheral artery disease is associated with arterial endothelial function.Mitochondrial Bioenergetics in the Metabolic Myopathy Accompanying Peripheral Artery Disease.Diminished force production and mitochondrial respiratory deficits are strain-dependent myopathies of subacute limb ischemia.Subacute limb ischemia induces skeletal muscle injury in genetically susceptible mice independent of vascular densitySkeletal muscle mitochondrial ATP production rate and walking performance in peripheral arterial disease.Blood pressure and leg deoxygenation are exaggerated during treadmill walking in patients with peripheral artery disease.Strain-Dependent Variation in Acute Ischemic Muscle Injury.Oxidative stress and antioxidant treatment in patients with peripheral artery disease.Peripheral artery disease, calf skeletal muscle mitochondrial DNA copy number, and functional performance
P2860
Q26774784-64E9445B-85DA-498A-9AD0-AE06E251E733Q27694706-7C4E543F-8B26-437A-BB83-03ECF89A00CCQ28250596-09B7AE68-3BB6-41B3-BAE3-7D56CD6B216EQ30419462-9103C453-739D-4190-8954-0B7C72874C32Q30422358-07742170-5909-417C-9004-FF42D4E6552DQ30426220-80D0F145-C2A8-4E1B-834E-2B621D49C782Q30435144-DAFB970E-0B52-4DF6-B560-3BD770DCDD3DQ33549031-DE675BD5-5815-4330-9CCD-908403134281Q33776561-D0F6215B-D298-4842-8E32-77A3FC61AE6CQ34634274-6F91B156-D4AD-4DC8-8964-20B852742792Q34730585-C5F25FC5-B7F8-42D4-A2D5-07AED9ED6E21Q35217900-A2E232BC-7D46-467A-A037-17EBD583703EQ35621136-A0056D3C-D398-43A0-A97C-CFCD083F9A1BQ35669151-32C9FE19-62D2-4310-9FE5-E7F25B1E7681Q35882665-8DAB1546-7EFC-4EBE-9740-F68E3AC208B0Q36274162-1DDFC148-8B88-469E-AE50-A595C2BDEEA1Q36549555-0B133CF1-90DF-41D1-9584-FE2F35A6B72EQ36598625-05B03741-8A16-4176-8931-9D4BFC3DCC8DQ36808114-2C2F9656-F263-4A15-8689-6865882120FBQ36981686-EFF9EF04-D58D-4E2F-B96C-58FCB3C8CB90Q37018405-06CABE40-EA54-4F01-93EB-FF5C6B989E41Q37094150-D7F8A8B7-607B-4D34-A867-8AB38117AE68Q37310417-AE6C7BEC-518A-44F6-A290-E718ED5A7EB1Q37346156-338D17D6-505A-45A2-B196-7C3DD19086D7Q37361610-A37F7B5C-AC00-4AAB-B892-40188D04BEB1Q37665969-F506E1D9-C921-4921-80A3-99459912A1A3Q37694486-51199BE4-1138-4F91-AE9B-F95EB564A88BQ41361706-68E32DDE-A424-41D3-8E88-BAA9B3C8269DQ41652067-C435A13D-FE04-487C-8C67-D2B21980FDF9Q44036430-F59FD82C-E061-45A0-B855-C1A662D66308Q48220141-2F720337-B347-410F-ABCE-C075ED6557DBQ49896979-246DFDA7-87F0-4CFB-85A2-B9EA42CA5056Q55005264-D6718927-CDCE-4E6A-ADCE-6243AC34F8E8Q58375352-F2C4FB22-FAEB-4EB7-AF6E-58D54A9F93BA
P2860
Acquired skeletal muscle metabolic myopathy in atherosclerotic peripheral arterial disease.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Acquired skeletal muscle metab ...... c peripheral arterial disease.
@ast
Acquired skeletal muscle metab ...... c peripheral arterial disease.
@en
type
label
Acquired skeletal muscle metab ...... c peripheral arterial disease.
@ast
Acquired skeletal muscle metab ...... c peripheral arterial disease.
@en
prefLabel
Acquired skeletal muscle metab ...... c peripheral arterial disease.
@ast
Acquired skeletal muscle metab ...... c peripheral arterial disease.
@en
P1433
P1476
Acquired skeletal muscle metab ...... c peripheral arterial disease.
@en
P2093
P356
10.1191/135886300669324268
P577
2000-01-01T00:00:00Z